background
v
j
recombin
take
place
lymphocyt
develop
gener
larg
repertoir
tand
bcell
receptor
mutat
recombinationactiv
gene
result
loss
reduct
v
j
recombin
known
differ
mutat
rag
gene
vari
residu
recombinas
activ
give
rise
broad
spectrum
clinic
phenotyp
object
sought
studi
immunolog
mechan
caus
clinic
spectrum
rag
defici
method
includ
patient
similar
mutat
result
ntermin
truncat
protein
residu
recombin
activ
present
differ
clinic
phenotyp
studi
precursor
bcell
develop
immunoglobulin
tcell
receptor
repertoir
format
receptor
edit
band
tcell
number
result
clinic
patient
divid
main
categori
b
sever
combin
immunodefici
omenn
syndrom
combin
immunodefici
patient
show
block
precursor
bcell
develop
low
band
tcell
number
normal
immunoglobulin
gene
use
limit
band
tcell
repertoir
slightli
impair
receptor
edit
conclus
studi
demonstr
similar
rag
mutat
result
similar
immunobiolog
effect
differ
clinic
phenotyp
indic
level
residu
recombinas
activ
determin
clinic
outcom
postul
model
type
moment
antigen
pressur
affect
clinic
phenotyp
patient
j
allergi
clin
immunol
defect
v
j
recombin
result
block
band
tcell
differenti
format
immunoglobulin
tcell
receptor
tr
perturb
result
combin
immunodefici
cid
b
cell
v
j
recombin
initi
recombinationactiv
gene
rag
protein
creat
doublestrand
break
immunoglobulin
tr
loci
subsequ
break
process
repair
protein
involv
nonhomolog
end
join
thu
far
genet
defect
identifi
artemi
ligas
iv
xlf
cernunno
dnapkc
gene
immunolog
phenotyp
clinic
present
mutat
differ
depend
type
genet
defect
ie
null
mutat
hypomorph
mutat
residu
v
j
recombin
activ
especi
rag
gene
mani
differ
mutat
describ
give
rise
residu
activ
mutat
rag
protein
differ
rag
mutat
result
broad
spectrum
clinic
phenotyp
includ
sever
combin
immunodefici
scid
rag
defici
ragd
skin
inflamm
ab
tcell
expans
classic
omenn
syndrom
os
ragd
skin
inflamm
without
tcell
expans
incomplet
os
ragd
maternofet
transfus
ragd
gd
tcell
expans
lateonset
scid
ragd
granuloma
ragd
cytopenia
thymu
hypoplasia
broad
spectrum
clinic
phenotyp
imped
time
recognit
ragd
might
thu
delay
treatment
hematopoiet
stem
cell
transplant
studi
select
patient
ragd
similar
ntermin
truncat
mutat
studi
effect
similar
mutat
clinic
phenotyp
patient
could
divid
main
clinic
phenotyp
ie
scid
os
cid
includ
phenotyp
studi
whether
key
immunolog
paramet
eg
precursor
bcell
develop
band
tcell
number
band
tcell
repertoir
might
explain
differ
clinic
phenotyp
peripher
blood
pb
bone
marrow
bm
clinic
data
obtain
accord
guidelin
medic
ethic
committe
erasmu
mc
rotterdam
flow
cytometr
analysi
perform
previous
describ
rag
analysi
vitro
v
j
recombin
assay
gene
amplifi
mean
pcr
sequenc
previous
describ
level
recombin
activ
express
construct
determin
use
recombin
plasmid
describ
previous
taqmanbas
realtim
quantit
rq
pcr
use
measur
transcript
level
bm
mononuclear
cell
describ
previous
tcell
receptor
b
analysi
tcell
receptor
b
trb
gene
rearrang
studi
describ
previous
vkck
junction
amplifi
multiplex
pcr
use
primer
specif
famili
vki
vkii
vkiii
vkiv
ck
primer
pcr
product
clone
pgemteasi
vector
promega
madison
wi
prepar
sequenc
abi
prism
xl
fluoresc
sequenc
appli
biosystem
foster
citi
calif
obtain
sequenc
analyz
imgt
databas
http
imgt
cinesfr
assign
vkand
jk
gene
product
uniqu
sequenc
use
determin
frequenc
vk
jk
gene
vhjh
junction
amplifi
postficol
pbmc
multiplex
pcr
use
jh
consensu
primer
primer
adapt
sequenc
ad
forward
revers
b
adaptor
tcag
key
multiplex
identifi
adaptor
pcr
product
purifi
use
gel
extract
qiagen
valencia
calif
agencourt
ampur
xp
bead
beckman
coulter
fullerton
calif
subsequ
pcr
concentr
measur
quantit
picogreen
dsdna
assay
invitrogen
carlsbad
calif
purifi
pcr
product
sequenc
gs
junior
instrument
accord
manufactur
recommend
use
gs
junior
titanium
empcr
kit
liba
sequenc
kit
picotiterpl
kit
life
scienc
roch
branford
conn
use
clc
genom
workbench
softwar
sampl
separ
base
multiplex
identifi
sequenc
trim
read
qualiti
score
less
less
bp
discard
read
upload
imgt
highvquest
softwar
subsequ
output
file
upload
custom
galaxi
platform
process
done
r
program
languag
gener
tabular
graphic
output
complementari
determin
region
amino
acid
pattern
visual
weblogo
http
weblogoberkeleyedu
statist
differ
absolut
number
lymphocyt
subset
analyz
use
test
independ
sampl
p
consid
signific
graphpad
prism
softwar
graphpad
softwar
la
jolla
calif
past
year
identifi
one
mutat
result
ntermin
truncat
mutat
patient
tabl
ii
hereaft
abbrevi
delt
hereaft
abbrevi
delaa
mutat
describ
sever
patient
found
hypomorph
translat
reiniti
altern
start
site
methionin
result
ntermin
truncat
protein
compar
residu
activ
compar
wild
type
fig
sixteen
patient
homozyg
delaa
delt
mutat
patient
compound
heterozyg
tabl
three
mutat
found
second
allel
also
analyz
vitro
recombin
assay
show
residu
activ
fig
addit
determin
presenc
polymorph
gene
might
influenc
recombin
activ
polymorph
found
shown
affect
recombin
activ
ntermin
truncat
mutat
result
spectrum
clinic
phenotyp
although
patient
similar
mutat
result
ntermin
truncat
protein
clinic
phenotyp
vari
substanti
patient
could
divid
main
clinic
phenotyp
classic
b
scid
n
os
n
cid
n
tabl
ii
patient
classic
scid
defin
low
band
tcell
number
age
diagnosi
first
year
life
patient
os
gener
pronounc
erythroderma
patient
cid
given
diagnosi
first
year
life
greater
gd
cell
normal
level
cell
despit
ntermin
truncat
patient
rang
clinic
phenotyp
strongli
suggest
factor
residu
activ
contribut
clinic
phenotyp
ragd
result
block
precursor
bcell
differenti
bm
bcell
stage
v
j
recombin
immunoglobulin
gene
take
place
rel
distribut
prob
prebi
prebii
immatur
b
cell
assess
bm
patient
investig
precursor
bcell
differenti
healthi
children
prob
prebi
cell
constitut
precursor
b
cell
fig
b
patient
classic
scid
os
except
show
complet
block
prebiicel
stage
fig
b
wherea
patient
cid
leaki
block
greater
prebii
immatur
b
cell
fig
b
transcript
level
determin
bm
mononuclear
cell
exclud
differ
transcript
level
caus
differ
precursor
bcell
composit
known
transcript
level
correl
level
bm
mononuclear
cell
depend
number
cell
express
rag
prebi
prebii
cell
studi
patient
transcript
level
correl
fig
c
indic
differ
sever
precursor
bcell
block
caus
differ
express
bcell
number
pb
undetect
low
patient
except
normal
level
tabl
ii
correl
percentag
prebii
immatur
cell
bm
number
peripher
b
cell
show
patient
greater
prebii
immatur
b
cell
bm
detect
b
cell
pb
collect
data
indic
patient
cid
milder
block
precursor
bcell
composit
patient
leaki
block
detect
b
cell
pb
patient
detect
peripher
b
cell
studi
igh
v
j
recombin
repertoir
igh
gene
rearrang
amplifi
mononuclear
cell
deriv
pb
bm
subsequ
sequenc
use
nextgener
sequenc
healthi
control
subject
pb
bm
patient
cid
frequenc
uniqu
sequenc
igh
gene
significantli
lower
patient
ragd
control
subject
tabl
iii
reflect
low
number
b
cell
present
pb
despit
low
recombin
activ
ighv
ighd
ighj
gene
use
restrict
fig
see
fig
articl
onlin
repositori
wwwjacionlineorg
fortyeight
ighv
gene
use
control
subject
identifi
patient
ragd
ighd
gene
ighj
gene
ighv
ighd
ighj
gene
use
similar
seen
control
subject
although
gene
use
differ
frequenc
fig
see
fig
strikingli
use
lower
wherea
use
higher
compar
seen
control
subject
patient
ragd
significantli
lower
frequenc
vs
control
subject
unproduct
rearrang
tabl
iii
report
previous
unproduct
rearrang
defin
outoffram
rearrang
rearrang
stop
codon
therefor
even
though
patient
ragd
reduc
v
j
recombin
lead
limit
tr
immunoglobulin
repertoir
igh
gene
use
similar
seen
control
subject
without
preferenti
use
proxim
distal
gene
os
character
autoimmunelik
clinic
featur
includ
sever
erythroderma
hepatosplenomegali
lymphadenopathi
immun
dysregul
patient
os
might
caus
sever
abnorm
thymic
architectur
impair
express
autoimmun
regul
tissuespecif
antigen
addit
hypomorph
rag
mous
model
shown
disturb
bcell
toler
addit
patient
os
also
patient
classic
scid
patient
cid
autoimmun
display
idiopath
thrombocytopen
purpura
autoimmun
hemolyt
anemia
tabl
unfortun
thymic
architectur
autoimmun
regul
tissuespecif
antigen
express
could
studi
patient
abl
evalu
paramet
igh
sequenc
associ
autoimmun
character
long
frequenc
known
encod
intrins
selfreact
cold
agglutinin
antibodi
recogn
carbohydr
antigen
erythrocyt
distribut
length
uniqu
junction
bm
pb
similar
seen
control
subject
fig
except
patient
seem
increas
number
junction
amino
acid
junction
length
amino
acid
display
high
similar
fig
b
sequenc
similar
found
compar
fig
b
junction
use
junction
highli
similar
sequenc
fig
b
suggest
might
recogn
common
antigen
determin
frequenc
long
amino
acid
significantli
lower
p
fig
c
frequenc
use
significantli
higher
p
p
fig
patient
analyz
autoimmun
reflect
high
frequenc
use
addit
select
long
bcell
toler
also
gener
receptor
edit
selfreact
b
cell
selfreact
b
cell
induc
express
rag
protein
edit
receptor
light
chain
avail
upstream
vk
downstream
jk
gene
chang
affin
receptor
therefor
vkjk
junction
amplifi
patient
os
patient
cid
igkv
gene
use
significantli
differ
seen
control
subject
fig
e
less
gene
use
patient
ragd
fig
f
therefor
receptor
edit
seem
partli
affect
deduc
low
use
hallmark
classic
os
expans
autolog
cell
hladr
phenotyp
oligoclon
ab
tcell
repertoir
consist
patient
os
normal
increas
tcell
number
addit
patient
cid
normal
number
wherea
patient
low
absolut
number
cell
tabl
ii
remark
mani
patient
high
percentag
gd
cell
includ
patient
classic
scid
patient
os
patient
cid
tabl
ii
addit
determin
tcell
prolifer
determin
dreccja
tcell
receptor
excis
circl
trec
content
per
ng
dna
patient
classic
scid
patient
os
patient
cid
patient
trec
detect
patient
number
ng
dna
less
compar
ng
dna
control
subject
n
age
month
year
data
shown
mean
cell
present
patient
show
extens
prolifer
furthermor
tcell
repertoir
determin
test
trb
gene
rearrang
patient
classic
scid
patient
os
patient
cid
patient
trb
repertoir
clearli
restrict
fig
taken
togeth
cell
present
patient
ragd
show
extens
prolifer
restrict
tr
repertoir
mani
differ
mutat
report
rag
mutat
databas
although
null
mutat
sever
describ
result
residu
recombinas
activ
previous
hypothes
null
mutat
would
result
classic
b
scid
partial
reduct
rag
activ
would
result
os
intermedi
lateonset
scid
os
phenotyp
last
year
spectrum
report
clinic
phenotyp
ragd
broaden
also
includ
ragd
gd
tcell
expans
ragd
skin
inflamm
without
tcell
expans
incomplet
os
ragd
granuloma
ragd
maternofet
transfus
ragd
cytopenia
thymu
hypoplasia
case
report
shown
rag
mutat
result
differ
clinic
phenotyp
studi
first
report
indepth
immunobiolog
evalu
patient
ragd
similar
mutat
result
ntermin
truncat
protein
similar
mutat
result
differ
clinic
phenotyp
indic
specif
mutat
predict
patient
clinic
phenotyp
patient
similar
mutat
residu
protein
activ
expect
compar
among
patient
ntermin
truncat
protein
produc
translat
start
altern
start
site
henc
amount
protein
depend
effici
start
site
use
transcript
level
correl
assum
patient
similar
express
mutant
protein
fig
c
exclud
epigenet
modifi
gene
account
small
differ
protein
express
although
previou
attempt
identifi
modifi
gene
human
subject
success
studi
mous
model
could
shed
light
contribut
epigenet
modifi
gene
cohort
v
j
recombin
complet
abolish
strongli
reduc
low
residu
activ
protein
reduc
v
j
recombin
character
normal
ighv
ighd
ighj
gene
use
without
preferenti
use
proxim
distal
gene
howev
shown
previous
frequenc
unproduct
sequenc
significantli
lower
healthi
control
subject
e
f
percentag
igkv
igkj
gene
determin
control
subject
patient
os
patient
cid
igkv
use
normal
fig
e
hardli
gene
use
fig
f
indic
b
cell
patient
ragd
correct
unproduct
rearrang
mean
recombin
second
igh
allel
consequ
reduc
v
j
recombin
fewer
b
cell
function
receptor
produc
prolifer
lymphocyt
increas
compens
low
circul
band
tcell
number
idea
corrobor
low
number
trec
patient
ragd
increas
prolifer
cell
might
result
normal
increas
tcell
count
especi
patient
os
howev
correspond
tr
repertoir
patient
ragd
remain
restrict
patient
ragd
show
clinic
sign
immun
dysregul
erythroderma
lymphadenopathi
hepatosplenomegali
idiopath
thrombocytopen
purpura
autoimmun
hemolyt
anemia
b
cell
shown
contribut
immun
dysregul
seen
rag
mous
model
sera
mice
contain
highaffin
antidoublestrand
dna
tissuespecif
autoantibodi
b
cell
display
impair
receptor
edit
addit
mice
increas
serum
b
cellactiv
factor
level
might
rescu
autoreact
bcell
clone
increas
serum
b
cellactiv
factor
level
also
seen
patient
rag
artemi
xlink
scid
similar
observ
mice
patient
ragd
use
gene
wherea
igkv
gene
use
normal
suggest
receptor
edit
group
patient
ragd
slightli
impair
either
result
reduc
recombin
activ
caus
mutat
low
bcell
number
lead
reduc
select
autoreact
b
cell
igh
repertoir
investig
long
increas
use
associ
autoreact
antibodi
patient
ragd
analyz
autoimmun
reflect
increas
gene
use
patient
divid
main
clinic
ragd
group
hardli
differ
immunobiolog
paramet
consequ
could
find
specif
pattern
could
explain
differ
clinic
phenotyp
basi
result
earlier
report
data
propos
explanatori
model
develop
differ
clinic
phenotyp
patient
ragd
similar
mutat
fig
ragd
result
reduc
v
j
recombin
low
band
tcell
number
produc
compensatori
clonal
expans
expans
might
increas
band
tcell
number
even
normal
level
chang
limit
repertoir
limit
repertoir
select
autoreact
cell
impair
provid
defici
immun
system
activ
patient
ragd
asymptomat
howev
immun
system
activ
potenti
wide
rang
differ
auto
antigen
type
antigen
activ
effector
lymphocyt
import
consequ
clinic
phenotyp
addit
impair
neg
posit
select
thymic
lymphocyt
reduc
number
regulatori
cell
might
result
autoimmun
patient
expos
autoantigen
phenomenon
occur
earli
stage
even
utero
shown
fact
patient
os
sever
erythroderma
alreadi
birth
unlik
trigger
infect
addit
directli
birth
skin
gastrointestin
tract
becom
colon
commens
bacteria
trigger
chronic
diarrhea
seen
patient
ragd
key
step
develop
certain
clinic
phenotyp
band
tcell
repertoir
type
auto
antigen
exposur
specif
antigen
receptor
time
cell
type
involv
immun
activ
potenti
influenc
genet
variat
modifi
gene
variabl
factor
might
eventu
lead
differ
clinic
phenotyp
despit
similar
genet
defect
conclus
studi
clearli
show
type
mutat
level
residu
recombinas
activ
determin
predict
clinic
phenotyp
previous
assum
clinic
outcom
individu
patient
ragd
depend
complex
interplay
limit
immun
receptor
repertoir
auto
antigen
exposur
specif
antigen
receptor
time
cell
type
involv
immun
activ
therefor
clinic
outcom
patient
ragd
similar
mutat
extrem
difficult
predict
thank
b
h
barendregt
picoknijnenburg
technic
assist
de
bruinversteeg
make
figur
zessen
help
repertoir
analysi
professor
j
cant
discuss
advic
clinic
implic
ragd
result
broad
spectrum
clinic
present
level
residu
rag
activ
alway
predict
clinic
outcom
